The Plus SideZ: A GLP-1 Guide to Metabolic Health
Looking for real information on GLP-1 medications and weight loss? You’re in the right place.
The Plus SideZ Podcast is your go-to space for science-backed conversations about obesity treatment, weight loss, and living with a chronic metabolic disorder. Hosted by Kim Carlos and Kat Carter, we explore GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound, featuring insights from leading obesity specialists, endocrinologists, and bariatric surgeons. But this podcast is about more than just medication—it’s about navigating the mental, emotional, and physical journey of reclaiming your health.
We combat misinformation with education from top experts, helping you think critically about the latest research, treatment options, and systemic challenges in obesity care. And at the heart of it all are the powerful, vulnerable stories of our brave community members—people sharing their real experiences on GLP-1 medications, breaking stigma, and taking control of their health.
Ranked in the top 1% of podcasts globally, The Plus SideZ Podcast has won three awards in just 18 months, including two Anthem Awards for social impact. Featured on Good Morning America, Bloomberg News, and ABC Nightline on Hulu, we’re at the forefront of the conversation on weight loss, obesity care, and the fight to end weight bias.
Join us and be part of a movement that’s changing the way the world understands obesity, health, and metabolic wellness.
Our Linktree
https://linktr.ee/theplussidez
Want to donate?
PayPal
https://www.paypal.com/donate/?hosted_button_id=ZSEE2DRPHDSZN
GoFundMe
https://gofund.me/82c8138e
Shop The Plus SideZ Merch Store
https://the-plus-sidez-podcast.printify.me/products/1
Website
https://theplussidez.com/
The Plus SideZ: A GLP-1 Guide to Metabolic Health
GLP-1 NEWS: Access at Risk – What Current Lawsuits and Legislation Mean
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
Linktree for Community Resources
https://linktr.ee/theplussidezpodcast
_________________________________________________________________________
In this episode, we break down the latest GLP-1 news around policy and legal developments impacting access to compounded GLP-1 medications in the United States.
We’re joined by special news correspondents Sabina Henn, an obesity advocate from GLPWinner.com, and Maria Rising, a GLP-1 reporter on TikTok and obesity advocate. Both are deeply involved in obesity care advocacy and work on and off the internet to protect patient access to treatment.
We begin with the broader national strategy shaping current GLP-1 policy, then walk through key federal and state actions, including the SAFE Drug Act (SR 6509), Indiana SB 282, and Florida SB 860 / HB 877. We explain how these bills could restrict access to compounded GLP-1 medications and why that poses a serious problem for patients who cannot take brand-name drugs or cannot afford them due to lack of insurance coverage and high costs.
We also cover the ongoing lawsuits between GLP-1 drug manufacturers and compounding pharmacies, including the Strive lawsuit, and examine the use of racketeering claims as a legal strategy. Throughout the episode, we focus on the real-world impact of these actions and how they could affect millions of patients relying on compounded GLP-1 medications for obesity and metabolic disease care.
We close with clear ways listeners can stay informed, engage, and help protect access to care.
Lawsuit Tracker
https://docs.google.com/spreadsheets/d/1XoaPEVWv5AxUJyoluaD-eExTPHK3GClIiV0xyI9rXqc/edit?usp=sharing
Follow Sabina:
Tiktok: https://www.tiktok.com/@lawliepop?lang=en
Instagram: https://www.instagram.com/glpwinner/
X: https://x.com/lawliepop?lang=en
YouTube: https://www.youtube.com/ @lawliepop
Follow Maria
TikTok
https://www.tiktok.com/@tirzepatidetales?_r=1&_t=ZP-93ELkA5nG9e
Substack
https://substack.com/search/tirzepatidetales?searching=profile
_________________________________________________________________________
Join this channel to get access to perks:
https://www.youtube.com/channel/UC0HUIGKl3BN4Vg6LYI-dkOA/join
_________________________________________________________________________
#Mounjaro #MounjaroJourney #Ozempic #Semaglutide #tirzepatide #GLP1 #Obesity #zepbound #wegovy #GLP1News
Kim Carlos, Executive Producer
Kat Carter, Producer
Podcasts we love
Check out these other fine podcasts recommended by us, not an algorithm.
